Financhill
Back

OncoCyte Stock Predictions

OncoCyte Stock Forecast

  • Is OncoCyte Stock Undervalued?
    The current OncoCyte [OCX] share price is $2.90. The Score for OCX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will OncoCyte Stock Go Up Next Year?

Data Unavailable

OncoCyte Stock Rating

Data Unavailable

OncoCyte Stock Price History

Is OCX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncocyte.com

52-Week Data

52-Week High:
4.34
52-Week Low:
2.29

Prediction Charts

Market Cap:
48.82M
Price in USD:
2.90
Volume:
24.84K
Beta:
1.93

Technical Analysis

SMA50:
3.04
SMA100:
3.05
SMA200:
2.95
52-Wk Change:
4.32%

Stock Predictions

  • Is OncoCyte stock public?
    Yes, OncoCyte is a publicly traded company.
  • What is the OncoCyte stock quote today?
    The OncoCyte stock price is 2.90 USD today.
  • How to buy OncoCyte stock online?
    You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 3.07 3.15 3.15 3.04
Oct-24 3.20 3.05 3.20 3.04
Oct-25 3.02 3.04 3.13 3.02
Oct-28 3.10 3.10 3.16 3.00
Oct-29 3.08 3.07 3.11 3.02
Oct-30 3.00 3.02 3.08 3.00
Oct-31 3.01 3.03 3.07 2.99
Nov-1 3.01 3.00 3.04 2.90
Nov-4 2.96 2.90 2.96 2.89
Nov-5 2.93 2.92 2.96 2.85
Nov-6 2.90 2.84 2.92 2.75
Nov-7 2.88 2.84 2.90 2.82
Nov-8 2.81 2.86 2.91 2.73
Nov-11 2.80 2.90 2.95 2.79

OncoCyte Earnings

Data Unavailable

OncoCyte Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.